Los Angeles Capital Management’s Core Laboratories CLB Stock Holding History

Los Angeles Capital Management’s Portfolio CLB Stock Details CLB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.39K	Sell	291 -21,710	-99%	-$310K	﹤0.01%	2201
2026 Q1	$369K	Buy	22,001 +11,815	+116%	+$211K	﹤0.01%	966
2025 Q4	$163K	Hold	10,186	–	–	﹤0.01%	1299
2025 Q3	$126K	Buy	+10,186	New	+$119K	﹤0.01%	1312
2015 Q1	–	Sell	-2,000	Closed	-$241K	–	1211
2014 Q4	$241K	Buy	+2,000	New	+$263K	﹤0.01%	1027
2014 Q3	–	Sell	-28,552	Closed	-$4.77M	–	1081
2014 Q2	$4.77M	Buy	28,552 +4,444	+18%	+$791K	0.05%	352
2014 Q1	$4.78M	Buy	+24,108	New	+$4.55M	0.05%	349

Other funds holding CLB

Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

DGI

Disciplined Growth Investors Minneapolis, Minnesota $5.91B AUM 53.97% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

CAMG

CWA Asset Management Group Naples, Florida $3.28B AUM 34.07% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Los Angeles Capital Management's CLB Position: Q2 2026 in Review

Los Angeles Capital Management reduced its Core Laboratories (CLB) stake by 99% in Q2 2026, selling an estimated $310K and leaving 291 shares worth $3.39K. The position accounts for ﹤0.01% of the portfolio, ranked #2201.

Los Angeles Capital Management first reported a position in CLB in Q1 2014 and has held it in 7 quarters since. The position peaked at $4.78M in Q1 2014. 186 funds tracked by Wall St. Rank hold CLB as of Q2 2026.

Los Angeles Capital Management held 291 shares of Core Laboratories worth $3.39K as of Q2 2026.
Los Angeles Capital Management sold 21,710 Core Laboratories shares in Q2 2026, an estimated $310K.
Core Laboratories made up ﹤0.01% of Los Angeles Capital Management's portfolio in Q2 2026, its #2201 holding.
Los Angeles Capital Management first reported a position in Core Laboratories in Q1 2014 and has held it in 7 quarters since.
Los Angeles Capital Management's Core Laboratories position peaked at $4.78M in Q1 2014.
186 funds tracked by Wall St. Rank held Core Laboratories as of Q2 2026.

Based on Los Angeles Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.